CHEK1 and neuroblastoma: Interestingly, simultaneous pharmacologic inhibition of CHEK1 and WEE1, both miR-497 targets, acted synergistically to impair neuroblastoma cell growth in vitro and in vivo [59], further demonstrating the therapeutic potential of miR-497.